Research
Hormonal
Mitochondrial dysfunction and ER stress are key mechanistic drivers of insulin resistance, primarily through the activation of inflammatory pathways and impaired insulin signaling.
Insulin resistance is driven by cellular stress in mitochondria and the ER, often caused by chronic overnutrition. Managing metabolic health involves reducing this cellular stress through balanced nutrition and activity, rather than just focusing on weight.
GoodSupportsHIGH confidence
Mitochondrial dysfunction and endoplasmic reticulum (ER) stress have been suggested to play a key role in insulin resistance development.
Why this rating
Strong mechanistic evidence from multiple animal and cell studies cited.
Source
Omega-3 Fatty Acids and Insulin Resistance: Focus on the Regulation of Mitochondria and Endoplasmic Reticulum Stress
Marilena Lepretti et al. · Nutrients · 2018
DOI 10.3390/nu10030350
narrative_reviewCited 225×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →